Profound Medical Corp. — Regulatory Filings 2024

Dec 2, 2024

6-K 1 f6k_120224.htm FORM 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2024

Commission File Number: 001-39032

PROFOUND MEDICAL CORP. (Translation of registrant's name into English)

2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5 (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ ] Form 40-F [ X ]

On December 2, 2024, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

(c) Exhibit 99.1. Press release dated December 2, 2024

EXHIBIT INDEX

The following document is attached as an exhibit hereto and is incorporated by reference herein:

Exhibit	Title
99.1	Press Release dated December 2, 2024

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	PROFOUND MEDICAL CORP.
	(Registrant)
Date: December 2, 2024	/s/ Rashed Dewan
	Rashed Dewan
	Chief Financial Officer